MichelleCareyMD
Endocrinology • Silver Spring, MDDiabetes, Lipid Metabolism
Clinical Team Leader; Division of Diabetes, Lipid Disorders, and Obesity; Office of New Drugs at U.S. Food and Drug Administration
Dr. Carey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
FDA White Oak Campus
Silver Spring, MD 20993
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011
Boston University School of MedicineClass of 2008
Certifications & Licensure
NY State Medical License 2009 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 33 citationsA Systematic Review of Innovative Diabetes Care Models in Low-and Middle-Income Countries (LMICs)Yonah B. Esterson, Michelle Carey, John D. Piette, Nihal Thomas, Meredith Hawkins
Journal of Health Care for the Poor and Underserved. 2014-02-01 - 35 citationsEvidence for central regulation of glucose metabolism.Michelle Carey, Sylvia Kehlenbrink, Meredith Hawkins
The Journal of Biological Chemistry. 2013-12-06 - 34 citationsImpact of hypoglycemia in hospitalized patients.Michelle Carey, Laura Boucai, Joel Zonszein
Current Diabetes Reports. 2013-02-01
Lectures
- Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight HumansAmerican Diabetes Association 74th Scientific Sessions - 6/15/2014
- Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in HumansAmerican Diabetes Association 74th Scientific Sessions - 6/15/2014
- Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin Sensitivity in HumansAmerican Diabetes Association 74th Scientific Sessions - 6/14/2014
- Join now to see all
Press Mentions
Poll Evaluation AnonymityFebruary 12th, 2016
FDA Approves New Class of Medicines To Treat Pediatric Type 2 DiabetesJune 22nd, 2023- FDA Grants Access to New Class of Paediatric Diabetes MedicineJune 22nd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
